Bone disease in patients with long-term renal transplantation and normal renal function

被引:102
作者
Carlini, RG
Rojas, E
Weisinger, JR
Lopez, M
Martinis, R
Arminio, A
Bellorin-Font, E
机构
[1] Hosp Univ Caracas, Ctr Nacl Dialisi & Trasplante, Caracas, Venezuela
[2] Hosp Univ Caracas, Div Nephrol, Caracas, Venezuela
关键词
renal transplantation; bone histomorphometry; parathyroid hormone (PTH); bone mineral density (BMD); renal osteodystrophy; renal transplant bone disease;
D O I
10.1053/ajkd.2000.8289
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal osteodystrophy may persist during the early years after renal transplantation. However, information on bone status after a successful long-term renal transplantation is limited. We examined biochemical parameters, bone mineral density (BMD), and bone histomorphometry in 25 asymptomatic men with normal renal function after 7.5 +/- 5.7 years of a renal transplantation. Serum calcium, phosphorus, alkaline phosphatase, and 1,25(OH)(2)D-3 levels and urinary calcium level and cyclic andenosine monophosphate excretion were within normal range in all patients. Serum intact parathyroid hormone (PTH) level was elevated in 11 subjects (133.6 +/- 78 pg/mL) and normal in the other 14 subjects (47.9 +/- 13.6 pg/mL). Mean BMD at the lumbar spine and femoral neck was low in the entire group. However, it progressively increased as time after transplantation increased, approaching normal values after 10 years. Bone histomorphometric analysis showed bone resorption, osteoid volume, and osteoid surface greater than normal range in the majority of patients. Bone formation rate and mineralization surface were low, and mineralization time was delayed in most patients. These lesions were more severe in patients after 3 to 4 years of transplantation but improved with time and approached normal values after a period of 10 years. PTH values did not correlate with bone histological characteristics or BMD. These results show that the bone alterations observed after long-term renal transplantation consist of a mixed bone disease in which features of high bone turnover coexist with altered bone formation and delayed mineralization. These findings may result from the combined effect of preexisting bone disease and immunosuppressive therapy. (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 39 条
[1]   CORTICOSTEROID-INDUCED OSTEOPOROSIS [J].
ADACHI, JD ;
BENSEN, WG ;
HODSMAN, AB .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 22 (06) :375-384
[2]   LOSS OF REGIONAL BONE-MINERAL DENSITY IN THE 1ST 12 MONTHS FOLLOWING RENAL-TRANSPLANTATION [J].
ALMOND, MK ;
KWAN, JTC ;
EVANS, K ;
CUNNINGHAM, J .
NEPHRON, 1994, 66 (01) :52-57
[3]  
AUBIA J, 1988, LANCET, V1, P1048
[4]   PREVENTION OF CANCELLOUS BONE LOSS BUT PERSISTENCE OF RENAL BONE-DISEASE DESPITE NORMAL 1,25 VITAMIN-D LEVELS 2 YEARS AFTER KIDNEY-TRANSPLANTATION [J].
BRINER, VA ;
THIEL, G ;
MONIERFAUGERE, MC ;
BOGNAR, B ;
LANDMANN, J ;
KAMBER, V ;
MALLUCHE, HH .
TRANSPLANTATION, 1995, 59 (10) :1393-1400
[5]   HEMODIALYSIS RELATED OSTEOMALACIA - A STAINING METHOD TO DEMONSTRATE ALUMINUM [J].
BUCHANAN, MRC ;
IHLE, BU ;
DUNN, CM .
JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (12) :1352-1354
[6]   Bone loss in long-term renal transplantation: Histopathology and densitometry analysis [J].
Cueto-Manzano, AM ;
Konel, S ;
Hutchison, AJ ;
Crowley, V ;
France, MW ;
Freemont, AJ ;
Adams, JE ;
Mawer, B ;
Gokal, R .
KIDNEY INTERNATIONAL, 1999, 55 (05) :2021-2029
[7]  
DALESSANDRO AM, 1989, SURGERY, V106, P1049
[8]   HYPERCALCEMIA AFTER RENAL-TRANSPLANTATION - LONG-TERM FOLLOW-UP DATA [J].
DAVID, DS ;
SAKAI, S ;
BRENNAN, BL ;
RIGGIO, RA ;
CHEIGH, J ;
STENZEL, KH ;
RUBIN, AL ;
SHERWOOD, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (08) :398-401
[9]   The fate of bone after renal transplantation [J].
Dissanayake, IR ;
Epstein, S .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1998, 7 (04) :389-395
[10]   LACK OF EVIDENCE THAT CYCLOSPORINE TREATMENT IMPAIRS CALCIUM-PHOSPHORUS HOMEOSTASIS AND BONE REMODELING IN NORMOCALCEMIC LONG-TERM RENAL-TRANSPLANT RECIPIENTS [J].
DUMOULIN, G ;
HORY, B ;
NGUYEN, NU ;
HENRIET, MT ;
BRESSON, C ;
REGNARD, J ;
SAINTHILLIER, Y .
TRANSPLANTATION, 1995, 59 (12) :1690-1694